2invest AG
Overview
2invest AG is a Germany-based publicly traded investment company that acquires, holds, manages, and sells investments in corporations and partnerships, with a focus on the biotechnology, life science, and IT sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Leucid Bio | Feb 2025 | Series A Extension | Lead |
| Kither Biotech | Mar 2022 | Series B | Lead |
| NeoPhore | Jan 2023 | Series B Extension | Co-investor |
| Heqet Therapeutics | Mar 2022 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is 2invest AG based?
2invest AG is headquartered in Heidelberg, Germany.
When was 2invest AG founded?
2invest AG was founded in 1997.
How many portfolio companies does 2invest AG have?
2invest AG has 4 portfolio companies in Caplight's dataset.
What are some companies in 2invest AG's portfolio?
Portfolio companies visible on Caplight include Leucid Bio, Kither Biotech, NeoPhore, Heqet Therapeutics.
What was 2invest AG's most recent investment shown here?
2invest AG's most recent investment in this portfolio sample was in Leucid Bio in 2025.
What sectors does 2invest AG focus on?
2invest AG focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does 2invest AG focus on?
2invest AG typically invests at the Mid stage.
What is 2invest AG's AUM?
2invest AG's assets under management are estimated between $0.0 and $50.0M.